Dr. Jochen Walz Chairman, EAU Section of Urological Imaging  (ESUI) Marseille (FR)
  walzj@ipc.u niconcer.fr
Leading international  experts active in imaging and image-guided treatment in urology gathered in  Barcelona on 12 November for the 4th Meeting of the EAU Section of Urological  Imaging (ESUI) which was held in conjunction with the 7th EMUC meeting.
  The meeting critically addressed the most recent developments  in imaging technologies and their clinical application in clinical practice. The  ESUI meeting not only complemented the EMUC meeting but also gave ESUI the  opportunity to offer a comprehensive programme with a high scientific quality.
  The sessions were all marked by a very lively discussion and  excellent interaction, proving that the idea of combining an imaging and multidisciplinary  oncology meeting responds to the needs and demands of physicians active in urological  oncology.
  Indeed, not only urologists participated in the meeting but  also radiologists, oncologists, nuclear medicine physicians and engineers.
  The meeting also had the support and participation of the  European Society of Urogenital Radiology (ESUR) and the European Association of  N u cl ear Medici ne
  (EANM) .The program me, aside from complementing to the EMU (programme,  offered key lectures that addressed the value of imaging in the management of urological  malignancies and a l so other urological fields such as stone and upper urinary  tract diseases.
  It is clear that the main advances in cancer management in  the future will be d riven by better imaging. Providing better detection,  better staging, better follow u p and salvage treatments will lead to improved  and individualised treatment strategies.
  This observation was a l so reflected in the meeting's theme  "Imaging and individualised  medicine."
  Outstanding presentations addressed key topics. Panel discussions  and audience feedback also generated a number of interesting conclusions and  participants went home with a set of actionable take-home messages and summaries,  some of which are listed below:
Imaging and  individualised medicine in urology
  One of the main observations with regards to imaging technologies  was that new developments added to the baseline technology will improve and  increase the information generated with the "conventional" tool.
  This is especially true for stone disease when using the  DYNA-CT, as well as for the management of upper urinary tract urothelial cancer  when using N BI , SPIES and POD. Moreover, high-resolution added to functional  imaging allows for an individualise the treatment of bladder and kidney cancers.
  
  
  New imaging  technologies on the horizon
  The fascinating session on new technologies proved that in the  near future even better performances in diagnostics an d treatment could be  expected. Especially ultrasound-based  imaging tools for prostate cancer  such as ultrafast ultrasound and ultra-high  frequency ultra sound will open up major possibilities  for improvements.
Joint ESUI and EANM  session
As i n 2014 one of the high lights of the meeting was the  joint meeting between the European Association of Nuclear Medicine ( EAN M) and  the ESUI. The role of PET/CT in the different urological malignancies was  critically assessed and clarified the value and limits of PET/CT in managing individual  pathology. It became obvious that nuclear medicine is very rapid lyevolving  with a large number of new tracers coming up, particularly for prostate cancer.  PSMA, in its derivatives, as well as Bombesin needs to be cited. The ESU I 2016  meeting will definitely continue this joint meeting to offer updates on new developments.
Best poster session  and best poster award
  The meeting also presented a successful poster session, with  the prize for the best poster granted to Dr. M. Hekman from Nijmegen (NL) for  her study entitled "Targeted dual-modality imaging in renal cell  carcinoma: An ex vivo kidney perfusion study."
  The number of abstracts submitted and published during the  meeting increased substantially and the quality can be commended. We are confident  future meetings will attract even more talented physicians, interested in  urological imaging, to submit their latest research to our meetings.
How can imaging  individualise and optimize PCa management?
  Dr. Christion  Pavlovich (Baltimore.USA) speaking on High resolution ultrasound in urology
  Another highlight was the session which addressed PCa imaging,  clearly one of the hottest topics in urological imaging. The session was opened  by an excellent point-a n d-counterpoint discussion between Hashim Ahmed (U K)  and this author who took pro and con positions regarding the capabilities of  multi parametric MRI to detect or rule out significant prostate cancer. The  debate followed by an in-depth assessment of new perspectives in ultrasound-  based imaging tools and their combination of   multiparametric ultrasound as well as in the critical assessment of multipara  metric MRI and its use in diagnosis, staging and treatment decision making. Finally,  the role of imaging in diagnosing and monitoring metastatic prostate cancer was  assessed.
Future ESUI meetings
  With the success of the 4th ESUI meeting, the 2016 meeting  is scheduled with the theme "Imaging and shifting paradigms in  urology" which will be held on 24 November, again in conjunction with the  8th EMUC in Milan. Save the date and see you in Milan!